Cannabinoid Receptor Types: The Short Answer
The endocannabinoid system works through two main receptor types: CB1 and CB2. CB1 receptors sit in high density in the brain and central nervous system, where they shape mood, memory, appetite, and pain signaling. CB2 receptors sit on immune cells and in peripheral tissue, where they take part in inflammation and immune response. A second tier of targets, including GPR55, TRPV1, PPAR-alpha, and the serotonin receptor 5-HT1A, also reacts to cannabinoids. That wider list explains why cannabis effects never fit a clean two-receptor model.
Understanding the Role of CB1 and CB2 Receptors in Cannabis
CB1 Receptors
CB1 is the most abundant cannabinoid receptor in the nervous system. It shows up in the cerebral cortex, hippocampus, cerebellum, and basal ganglia. The hippocampus handles memory, the cerebellum handles coordination, and the basal ganglia handle movement and reward. That spread is why THC can shift memory, timing, and appetite at the same time.
What binds to CB1
The body's own endocannabinoid anandamide and 2-AG bind CB1. THC binds CB1 as a partial agonist, which means it activates the receptor but not to the maximum level. CBD has low affinity for CB1 and can act as a negative allosteric modulator, changing how the receptor responds to other compounds.
CB2 Receptors
CB2 receptors cluster on immune tissue: spleen, tonsils, thymus, and white blood cells such as macrophages and B cells. They appear in the brain at far lower levels, often after injury or inflammation. This pattern points to a role in immune signaling rather than the psychoactive effects tied to CB1.
CBD vs THC: A Comprehensive Comparison Review
What binds to CB2
2-AG shows higher affinity for CB2 than anandamide. THC binds CB2 with lower potency than it binds CB1. Many synthetic cannabinoid drugs were designed for CB2 selectivity in research settings, not for consumer use.
Receptors Beyond CB1 and CB2
- GPR55. An orphan receptor that some researchers classify as a third cannabinoid receptor. It responds to certain phytocannabinoids and to lysophosphatidylinositol.
- TRPV1. A vanilloid receptor involved in heat and pain sensing. CBD and CBC can act on it.
- PPAR-alpha and PPAR-gamma. Nuclear receptors tied to metabolism and gene expression. CBD shows activity here in lab work.
- 5-HT1A. A serotonin receptor. CBD acts as an agonist at this site, which is one reason CBD effects look different from THC effects.
How THC and CBD Differ at the Receptor
THC is a partial agonist at CB1 and CB2, so it switches those receptors on. CBD does not switch CB1 on in the same way. CBD shows low affinity for CB1 and CB2, blocks some CB1 activity through negative allosteric modulation, and works on several non-cannabinoid targets. A high-THC flower and a high-CBD flower can feel nothing alike even when both come from the same plant species.
Using Receptor Basics When You Choose a Product
- Read the certificate of analysis on the product page and note the THC and CBD percentages.
- Decide which side of the ratio you want: THC-forward, CBD-forward, or a balanced mix.
- Pick the lowest dose that covers your goal, especially with THC-forward products.
- Record the strain, dose, and timing in a note on your phone.
- Adjust one variable at a time on your next session.
This article is educational and is not medical advice. Talk to a licensed clinician about cannabis and any medication you take.
Key Takeaways
- CB1 is the brain and central nervous system receptor.
- CB2 is the immune and peripheral tissue receptor.
- THC activates both CB1 and CB2 as a partial agonist.
- CBD has low affinity for CB1 and CB2 and acts on other targets.
- GPR55, TRPV1, PPAR-alpha, and 5-HT1A add to the picture.